- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT02786225
Collaboration for Antepartum Risk Evaluation (CARE)
Interprofessional Perinatal Consults to Improve Communication Quality, Satisfaction, and Team Cohesion: A Randomized Trial of the Collaboration for Antepartum Risk Evaluation (CARE) Model
Přehled studie
Postavení
Podmínky
Detailní popis
Perinatal outcomes in the United States rank below many other developed countries. National organizations, such as the American College of Obstetricians and Gynecologists, have called for women to utilize the level and provider of maternity services that meet their personal and medical needs. This leveled approach to care requires consultation and collaboration among providers to ensure women receive appropriate services. While national and international organizations have called for team-based maternity care, current models can fragment services, increasing the risk of communication errors. Women can feel disenfranchised by models that do not meet their needs and opt out of beneficial services altogether.
Currently, there is not evidence on effective interdisciplinary models of maternity care. The Collaboration for Antepartum Risk Evaluation (CARE) study will use a randomized design to systematically test the effect of interdisciplinary consults on women and providers. The two aims of the study are: (1) evaluate the effect of collaborative vs individual consults on participant outcomes including communication quality (using the Communication Assessment Tool, team version), maternal satisfaction (using a modified Satisfaction with Prenatal Care measure), semi-structured interviews, adherence to the developed plan of care, and perinatal outcomes; (2) evaluate the effect of the CARE clinic on providers using the Communication Assessment Tool- team version, the Agency for Healthcare Research and Quality (AHRQ) Team Strategies and Tools to Enhance Performance and Patient Safety (TeamSTEPPS) questionnaire, and semi-structured interviews.
The CARE study will provide valuable information on effective models for patient-centered maternity care. The AHRQ K08 will allow Dr. Philippi to implement the CARE study and facilitate her growth into a national leader in midwifery and health services research.
Typ studie
Zápis (Aktuální)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
Tennessee
-
Nashville, Tennessee, Spojené státy, 37240
- Vanderbilt School of Nursing
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- Adult pregnant women receiving prenatal care at the VUSN Nurse-Midwifery Faculty Practice.
- Gestational age of pregnancy 4-40 weeks
- Needs a consultation with perinatologist for one of the following reasons:
Prior pregnancy with congenital abnormality History of fetal demise >20 weeks History of preterm labor in previous pregnancy Current maternal drug or alcohol abuse Controlled maternal condition (e.g. thyroid disorder) Mild abnormality of fetus or placenta on ultrasound Idiopathic thrombocytopenia in pregnancy
- Can attend the collaborative care clinic
Exclusion Criteria:
- Unable to give consent for research participation - including age < 18 or impaired mental function
- Urgent medical condition requiring immediate assessment including: ectopic pregnancy or vaginal bleeding
- Medical conditions outside of scope of VUSN midwifery guidelines including:
Chronic maternal conditions requiring specialist involvement including: HIV, epilepsy, uncontrolled asthma, and liver, renal, cardiac disease.
Multiple gestation > 2 previous cesarean births Rh isoimmunization Incompetent cervix Major fetal or placenta abnormalities
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Výzkum zdravotnických služeb
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Collaborative Care
Intervention Group: Women (n=118) will be seen one time, simultaneously by a Vanderbilt University Medical Center (VUMC) perinatologist and a Vanderbilt University School of Nursing (VUSN) nurse-midwife (the CARE visit).
During the CARE visit, the nurse-midwife and perinatologist will complete the CARE checklist The checklist will be signed by the woman and providers and scanned into the medical record.
Following the CARE visit, women will return to midwifery care or be referred to perinatology depending on their needs, remaining in the study.
Women returning to the midwifery practice will see a primary midwife for the remainder of care.
|
Intervention Group: Women (n=118) will be seen one time, simultaneously by a VUMC perinatologist and a VUSN nurse-midwife (the CARE visit).
During the CARE visit, the nurse-midwife and perinatologist will complete the CARE checklist The checklist will be signed by the woman and providers and scanned into the medical record.
Following the CARE visit, women will return to midwifery care or be referred to perinatology depending on their needs, remaining in the study.
Women returning to the midwifery practice will see a primary midwife for the remainder of care.
|
|
Aktivní komparátor: Comparison Care- Usual Care + primary midwife
Comparison Group: Usual care enhanced with primary midwife.
Women in the comparison group (n=118) will receive the standard individual consult visit with a perinatologist and then, if they return to midwifery care, have one consistent midwife (primary midwife) for the majority of remaining prenatal care.
|
Comparison Group: Usual care enhanced with primary midwife.
Women in the comparison group (n=118) will receive the standard individual consult visit with a perinatologist and then, if they return to midwifery care, have one consistent midwife (primary midwife) for the majority of remaining prenatal care.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Communication Assessment Tool (CAT)-Team survey
Časové okno: 2 weeks after intervention/comparison visit
|
The CAT, developed by Makoul et al., assesses views of provider communication via 14 Likert responses ranging from 1= 'poor' to 5= 'excellent.
|
2 weeks after intervention/comparison visit
|
|
Satisfaction with Prenatal Care (SPC) scale
Časové okno: 2 weeks after intervention/comparison visit
|
The SPC scale assesses patient satisfaction with prenatal care
|
2 weeks after intervention/comparison visit
|
|
Communication Assessment Tool (CAT)-Team survey - following birth
Časové okno: Within 2 weeks after patient gives birth
|
The CAT, developed by Makoul et al., assesses views of provider communication via 14 Likert responses ranging from 1= 'poor' to 5= 'excellent.
|
Within 2 weeks after patient gives birth
|
|
Satisfaction with Prenatal Care (SPC) scale - following birth
Časové okno: Within 2 weeks after patient gives birth
|
The SPC scale assesses patient satisfaction with prenatal care
|
Within 2 weeks after patient gives birth
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Smoking at 1st prenatal visit
Časové okno: 1 week after the patient gives birth
|
1 week after the patient gives birth
|
|
|
For smokers, number of cigarettes per day
Časové okno: 1 week after the patient gives birth
|
Number of cigarettes per day
|
1 week after the patient gives birth
|
|
Location of birth
Časové okno: 1 week after patient gives birth
|
Location where the mother gave birth - Vanderbilt / Other hospital, Birth center, Home, En Route
|
1 week after patient gives birth
|
|
Provider at admission to labor and delivery
Časové okno: 1 week after patient gives birth
|
Medical care provider at the time of admission in labor
|
1 week after patient gives birth
|
|
Patient & provider adherence to checklist plan
Časové okno: 1 week after patient gives birth
|
Congruence between the anticipated plan of care at the time of the intervention/comparison visit and what occurred at the time of birth
|
1 week after patient gives birth
|
|
Gestational age at birth
Časové okno: 1 week after patient gives birth
|
the gestational age of the baby at the time of birth - in weeks+days
|
1 week after patient gives birth
|
|
Infant birth weight
Časové okno: 1 week after patient gives birth
|
Infant birth weight in grams as collected within 4 hours of birth
|
1 week after patient gives birth
|
|
Mode of birth
Časové okno: 1 week after patient gives birth
|
Number of women giving birth via 1 of 4 methods: vaginal/assisted vaginal/cesarean after labor/planned cesarean
|
1 week after patient gives birth
|
|
Trial of labor after cesarean
Časové okno: 1 week after the mother gives birth
|
Whether the woman was attempting a trial of labor after a previous cesarean birth
|
1 week after the mother gives birth
|
|
Vaginal birth after cesarean
Časové okno: 1 week after patient gives birth
|
Whether the woman gave birth vaginally with this infant after she had a previous cesarean birth.
|
1 week after patient gives birth
|
|
Complications at birth
Časové okno: 1 week after patient gives birth
|
The presence of any adverse outcomes during pregnancy, birth, postpartum, including details
|
1 week after patient gives birth
|
|
Breastfeeding at birth
Časové okno: 1 week after patient gives birth
|
Breastmilk feeding of the infant at the time of birth
|
1 week after patient gives birth
|
|
Breastfeeding at discharge
Časové okno: 1 week after patient gives birth
|
Breastmilk feeding of the infant at the time of discharge.
|
1 week after patient gives birth
|
|
Hospital stay postpartum
Časové okno: 1 week after patient gives birth
|
Lengths of postpartum hospital stay in calendar days
|
1 week after patient gives birth
|
|
Generalized Anxiety Disorder 7-item scale (GAD-7)
Časové okno: 2 weeks after intervention/comparison visit
|
Measure of anxiety level.
Scale can range from 0-21 with higher scores representing greater anxiety.
|
2 weeks after intervention/comparison visit
|
|
Generalized Anxiety Disorder 7-item scale (GAD-7)
Časové okno: Within 2 weeks after patient gives birth
|
Measure of anxiety level.
Scale can range from 0-21 with higher scores representing greater anxiety.
|
Within 2 weeks after patient gives birth
|
Spolupracovníci a vyšetřovatelé
Sponzor
Vyšetřovatelé
- Vrchní vyšetřovatel: Julia Phillippi, PhD, Vanderbilt School of Nursing
Publikace a užitečné odkazy
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další identifikační čísla studie
- 160523
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Popis plánu IPD
Časový rámec sdílení IPD
Kritéria přístupu pro sdílení IPD
Typ podpůrných informací pro sdílení IPD
- PROTOKOL STUDY
- MÍZA
- ICF
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Collaborative Care
-
Xuanwu Hospital, BeijingBioray LaboratoriesZatím nenabírámeRoztroušená skleróza | Neuromyelitida Poruchy optického spektra | Chronická zánětlivá demyelinizační polyradikuloneuropatie | Myasthenia Gravis, generalizovanáČína
-
The Second Hospital of Shandong UniversityAktivní, ne nábor
-
Cellular Biomedicine Group Ltd.The First Affiliated Hospital with Nanjing Medical UniversityDokončenoRefrakterní difúzní velký B-buněčný lymfomČína
-
Stephan Grupp MD PhDChildren's Hospital of Philadelphia; Children's Cancer Research Fund; Alliance...NáborVysoce rizikový neuroblastom | Refrakterní neuroblastom | Recidivující neuroblastomSpojené státy
-
Daniel LandiUkončenoGlioblastom | GliosarkomSpojené státy
-
The Second Hospital of Shandong UniversityAktivní, ne náborBezpečnost a účinnost buněčných léků, objektivní míra odpovědi subjektů atd.Čína
-
Zhejiang UniversityCarbiogene Therapeutics Co. Ltd.NáborPokročilý hepatocelulární karcinomČína
-
Nexcella Inc.Immix Biopharma, Inc.NáborAmyloidóza lehkého řetězce (AL).Spojené státy
-
Second Affiliated Hospital, School of Medicine,...NáborRecidivující a refrakterní B-buněčný lymfomČína
-
Second Affiliated Hospital, School of Medicine,...NáborB-buněčný non Hodgkinův lymfomČína